Immunology and Microbiology
Avadomide
100%
Immunotherapy
100%
T Cell
100%
Interferon Type I
100%
Programmed Death-Ligand 1
100%
Chemokine
33%
Interferon Gamma
16%
Xenograft
16%
Antineoplastic Activity
16%
B Cell
16%
Synapse
16%
Cytotoxic T-Cell
16%
Leukemia Cell
16%
T Cell Activation
16%
Programmed Death 1 Ligand 1
16%
Upregulation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Avadomide
100%
Chronic Lymphatic Leukemia
100%
Interferon
100%
Immunotherapy
100%
Combination Therapy
50%
Chemokine
33%
Neoplasm
33%
Programmed Death 1 Ligand 1
16%
Nonhodgkin Lymphoma
16%
Tumor Microenvironment
16%
Ligase
16%
Interferon Type I
16%
CD8 Antigen
16%
Malignant Neoplasm
16%
Interferon Type II
16%
Hodgkin Disease
16%